SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 2024 Biotech Charity Contest

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: technetium who wrote (67)4/29/2024 8:16:24 PM
From: technetium1 Recommendation

Recommended By
BulbaMan

  Read Replies (2) of 97
 
*A figure emerges from a pile of bed spreads and duvets, looking around cautiously. He sniffs the air, then eyes the old ticker tape machine, churning out the market activity (it is restricted to following only the contest stocks and even then it frequently falls behind). Next to it is a boxy shape on a desk covered by a sheet. He whisks away the sheet to reveal a home-brew Bloomberg terminal, which he ignores. Instead he takes the sheet to a very large table, and with a snap spreads it out flat. He gingerly examines the entrails printed on the spread sheet …*

Well gang. This is better. Only a little, but still better.The NASDAQ snapped out of its multi-week swoon (+4%) and both biotech composites were in the black, but not enough to make either a winner YTD.

The contest stocks also had a more normal week: some winners, some losers, not like last week where it was hard to spot any black in a sea of red ink.

This week’s big winner was the marauders at VKTX, whose quarterly report, released Wednesday after market, “exceeded expectations”, one reason for its 58% return for the week, which packed on a little more padding to keep it number one YTD at +300%.l. Also it doesn’t hurt that almost every week Motley Fool and other analysts cover it with an article at least every other day, only rarely negative.

Second place BCAB (+18%) released their intent to attend an upcoming meeting. For third place, SERA (+17%) announced the date for the quarterlies, which was enough to put it on the top five YTD list in fifth. IMMP in fourth (also +17%) announced positive preliminary results.

On the losing side it’s tough sometimes to deduce any rhyme or reason for a drop. CRDF was the worst for the week , dropping -19%, just by scheduling a quarterly earnings release for next week, though not so bad to disturb its position in second place for the YTD (+180%). ALLO (-18%) had Zacks predict that they would exceed expectations both in an earrings report and perhaps clinical results. JSPR’s loss of -15% didn’t perturb its THIRD place position YTD return (+160%). GLYC (-12% for the week) also had the temerity to announce when their quarterly results will be announced in two weeks. And OCUL's -11% was undoubtedly caused by Motley Fool designating it as one of “Two Small-Cap Growth Stocks With Room to Run”.

Though generally not a big enough loser to make it to the weekly worst five, a long slide since New Year’s has finally been recognized; they are the fifth worst YTD stock, -61%.

Looking at the contest portfolios, this week posted a modest gain of +$1.5k on the value of an average portfolio, allowing the average YTD to move in the correct direction (up) to +$2.8k. in addition twelve portfolios managed to be in the black for the week

Led by a 15% position in VKTX, BULBAMAN had the best return for the week (+$9.5k), while BLADERUNNER had the worst (-$2.2k) by virtue(?) of having chosen the worst, third worst, and fourth worst stocks for the week. The net effect is that BLADERUNNER is still in first YTD (+$57k), but by an incredibly thin margin, only $116 separating them from BULBAMAN in second.

TECHNETIUM's second place return for the week, +$8.3k, was enough to bump them up from sixth to fifth YTD, +$12.9k. They also have a position in VKTX.

In fifth and sixth place in the weekly returns we see: RAJU_BIJLEE +$2.2k (investor in VKTX) verses ERIKOTTO, $960, (not holding any VKTX). The difference is enough that they have exchanged places on the YTD list, RAJU_BIJLEE in third now (+$19k), and ERIKOTTO fourth (+$18k).

DEW_DILIGENCE in seventh for the week, +$830 (They have VKTX, but unfortunately other positions did not go as well) which bumped them up one step in the YTD standings to sixth (+$4.7k).

Seven contestants are net positive for the year at this point.

Report Time Ranges











From

To

















Recent

4/19/2024

4/26/24

















YTD

12/31/2023









Index Portfolios’ Performance









Symbol

Recent P/L

Recent %

YTD P/L

















^IXIC

$4,302.68

4.2%

$6,105.69

















^NBI

$1,603.63

1.7%

-$5,402.55

















^SPSIBI

$859.43

0.9%

-$6,417.15









Share Performance

Recent Performance

YTD Performance



Top Five



Bottom Five



Top Five



Bottom 5

Symbol

P/L / Initial Price

Symbol

P/L / Initial Price

Symbol

YTD P/L / Initial Price

Symbol

YTD P/L/ Initial Price

VKTX

58.5%

CRDF

-18.9%

VKTX

299.3%

AMLX

-88.0%

BCAB

17.7%

ALLO

-18.1%

CRDF

175.0%

PACB

-85.0%

SERA

16.7%

JSPR

-15.1%

JSPR

158.6%

CNSP

-83.1%

IMMP

16.7%

GLYC

-12.1%

PYXS

138.9%

EYEN

-69.8%

TARA

15.2%

OCUL

-10.7%

SERA

79.8%

RVNC

-61.3%

Average and Median Portfolio Performance



Recent P/L







YTD P/L







Avg.

Median







Avg

Median







$1,452.34

$731.44

JR_95



$2,847.77

-$6,074.08

TOMATO

Top Seven Portfolio Performances

Top Recent Performers

Top YTD Performers

Contestant (Prev. Rank)

Recent P/L

P/L vs. ^SPSIBI

YTD P/L (Rank)

Contestant (Prev. Rank)

YTD P/L

vs. Top Portfolio

P/L vs. ^SPSIBI

Rec. P/L (Rank)

1 - BULBAMAN (8)

$9,499.57

$8,640.14

$56,654.65 (2)

1 - BLADERUNNER (1)

$56,770.90

——

$63,188.05

-$2,162.98 (17)

2 - TECHNETIUM (6)

$8,266.16

$7,406.73

$12,886.40 (5)

2 - BULBAMAN (2)

$56,654.65

$116.25

$63,071.80

$9,499.57 (1)

3 - DART LANZER (3)

$2,578.74

$1,719.31

-$8,193.54 (10)

3 - RAJU_BIJLEE (4)

$19,086.32

$37,684.58

$25,503.47

$2,248.80 (5)

4 - A. J. MULLEN (7)

$2,414.26

$1,554.83

-$28,906.93 (17)

4 - ERIKOTTO (3)

$17,986.28

$38,784.62

$24,403.43

$959.26 (6)

5 - RAJU_BIJLEE (16)

$2,248.80

$1,389.38

$19,086.32 (3)

5 - TECHNETIUM (6)

$12,886.40

$43,884.50

$19,303.55

$8,266.16 (2)

6 - ERIKOTTO (15)

$959.26

$99.83

$17,986.28 (4)

6 - DEW_DILIGENCE (7)

$4,730.61

$52,040.29

$11,147.77

$827.43 (7)

7 - DEW_DILIGENCE (12)

$827.43

-$32.00

$4,730.61 (6)

7 - TRACE I11 (5)

$4,050.03

$52,720.87

$10,467.18

-$1,064.14 (16)

8 - JACK HARTMANN (9)

$776.42

-$83.00

-$2,452.56 (8)

8 - JACK HARTMANN (8)

-$2,452.56

$59,223.46

$3,964.59

$776.42 (8)

Top Portfolios’ Contents

Top Recent Performance Portfolio (BULBAMAN)

Top YTD Performance Portfolio (BLADERUNNER)

Symbol (Rank)

Initial Allocation

Value/Total | ROI

YTD Stock P/L

Recent Stock P/L

% Current Price Change for $1,000 P/L

Symbol (Rank)

Initial Allocation

Value/Total | ROI

YTD Stock P/L

Recent Stock P/L

% Current Price Change for $1,000 P/L

CU6.AX

20.00%

16.3% | 27.7%

$5,549.05

-$1,531.24

3.9%

BCAB

10.00%

6.6% | 3.3%

$325.20

$1,768.29

9.7%

CYTH

10.00%

5.1% | -20.8%

-$2,075.47

$628.93

12.6%

CRDF

20.00%

35.1% | 175.0%

$35,000.00

-$3,783.78

1.8%

LRMR

10.00%

9.0% | 41.5%

$4,153.85

-$197.80

7.1%

CRIS

10.00%

7.2% | 13.5%

$1,349.02

$125.49

8.8%

PMN

10.00%

11.0% | 72.2%

$7,217.39

$260.87

5.8%

GLYC

10.00%

4.4% | -30.5%

-$3,050.85

-$1,207.63

14.4%

SNGX

10.00%

3.5% | -45.4%

-$4,539.47

-$210.53

18.3%

IMMP

10.00%

7.0% | 10.4%

$1,041.67

$1,666.67

9.1%

TCON

10.00%

3.3% | -48.3%

-$4,831.52

-$428.33

19.3%

IOVA

20.00%

18.3% | 43.2%

$8,634.69

$811.81

3.5%

TLX.AX

15.00%

13.6% | 41.9%

$6,285.62

$2,200.13

4.7%

JSPR

10.00%

16.5% | 158.6%

$15,855.51

-$1,508.24

3.9%

VKTX

15.00%

38.2% | 299.3%

$44,895.22

$8,777.54

1.7%

REPL

10.00%

4.9% | -23.8%

-$2,384.34

-$35.59

13.1%

















































Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext